-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Spero Therapeutics, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q3 2022 to Q3 2023.
- Spero Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $2.21M.
- Spero Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $2.6M.
- Spero Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
- Spero Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)